Holocene

Evoke Pharma Reports Fourth Quarter and Full Year 2021 Financial Results

Retrieved on: 
Tuesday, March 8, 2022
TD, Stomach, Hypertension, NMS, Risk, Creatinine, Prescription, Private Securities Litigation Reform Act, Depression, Internal bleeding, Extrapyramidal symptoms, EPS, Metoclopramide, Practitioner, HCPS, LinkedIn, Kidney, Suicide, Marketing, Facebook, FDA, Liver, Suicidal ideation, Dysgeusia, Seizure, Pheochromocytoma, Gastroparesis, Fatigue, GLOBE, Perforation, Patient, Organization, CEO, Awareness, Evoke, CYP2D6, NASDAQ, Parkinsonism, Research, Methemoglobinemia, United, Neoplasm, Physiology, History, Epilepsy, Lists of diseases, Gastroenterology, Twitter, Hypersensitivity, Neuroleptic malignant syndrome, Tardive dyskinesia, U.S. Securities and Exchange Commission, Water, Holocene, Catecholamine, Absorption, COVID-19, Net, Hyperprolactinaemia, Headache, Bronchospasm, Pharmaceutical industry, Medicine, Aroma compound, Residential care, Generic drug

SOLANA BEACH, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2021, and recent corporate developments.

Key Points: 
  • Our net product sales from prescriptions increased sequentially by 46%, to $361,000 in the fourth quarter of 2021 from $247,000 in the third quarter.
  • Fourth Quarter 2021 Developments and Recent Progress:
    Conducted higher number of in-person meetings with HCPs in many areas of the U.S.
  • Research and development expenses totaled approximately $36,000 for the fourth quarter of 2021 compared with $0.1 million for the fourth quarter of 2020.
  • For the fourth quarter of 2021, selling, general and administrative expenses were approximately $1.7 million compared with $2.0 million for the fourth quarter of 2020.

InspireMD Reports Fourth Quarter and Year-End 2021 Financial Results

Retrieved on: 
Tuesday, March 8, 2022
JACC, Host, Holocene, Adoption, Omicron, Micronet, Leadership, Patient, Clinical trial, Hospital, Industry, Stenosis, Food, Abbott, Coronavirus Scientific Advisory Board (Turkey), EPS, Board of directors, FDA, Growth, 2006–2007 economic sanctions against the Palestinian National Authority, Board, Goal, COVID-19, HAS, Conference, NSPR, Marketing, CEO, TCAR, TEL, Stroke, American College, American College of Cardiology, Nasdaq, IDE, GLOBE, Video game, Pharmaceutical industry, Animal, Director

--Management to Host Investor Conference Call Today, March 8, at 8:30am ET--

Key Points: 
  • Financial Results for the Fourth Quarter ended December 31, 2021
    For the fourth quarter of 2021, revenue increased by $1,222,000, or 773.8%, to $1,380,000, from $158,000 during the fourth quarter of 2020.
  • For the fourth quarter of 2021, gross profit increased $684,000, to $294,000, compared to a gross loss of $390,000 for the fourth quarter of 2020.
  • For the fourth quarter of 2021, total operating expenses were $4,225,000, an increase of $897,000, or 27.0% compared to $3,328,000 for the fourth quarter of 2020.
  • For the fourth quarter of 2021, financial expenses decreased by 7.6%, or $10,000, to $121,000, from $131,000 during the fourth quarter of 2020.

China Non-Invasive Prenatal Testing Market Report 2022: Size, Trends, Share, Growth, Opportunity, and Forecasts 2018-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 1, 2022
Surgery, Health, Holocene, NIPT, CAGR, Industry, USD, Medical imaging, Growth

This new market report presents a comprehensive study of the entire China non-invasive prenatal testing market.

Key Points: 
  • This new market report presents a comprehensive study of the entire China non-invasive prenatal testing market.
  • The report offers the most up-to-date industry data on the actual market situation and future outlook for the China non-invasive prenatal testing market.
  • The report also explores the detailed description of market drivers and inhibitors of the China non-invasive prenatal testing market.
  • This Comprehensive China Non-Invasive Prenatal Testing Market Research Report Provides:
    A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development
    The Leading Companies for the China Non-Invasive Prenatal Testing Market are Listed Below:

Minerva Surgical to Announce Fourth Quarter and Full-Year Financial Results

Retrieved on: 
Tuesday, February 22, 2022
GLOBE, Nasdaq, Holocene, Hysterectomy, Woman, Uterus, Abnormal uterine bleeding, Minerva, AUB, Telephone, Interest, Medical device

SANTA CLARA, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its fourth quarter and full-year 2021 financial results on Tuesday, March 8, 2022.

Key Points: 
  • SANTA CLARA, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its fourth quarter and full-year 2021 financial results on Tuesday, March 8, 2022.
  • In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
  • The live webinar of the call may be accessed by visiting the Recent Events section of the companys website at http://ir.minervasurgical.com .
  • Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women.

India Smartphone Market to 2028 - Featuring Xiaomi, Vivo and Samsung Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, February 21, 2022
Mobile, Wireless, Technology, Telecommunications, Holocene, Growth, Major, Smartphone, Driver, Industry, Physical restraint, US, Top-line growth, CAGR, Mobile phone

Some of the Major Factors Contributing to the Growth of the Market:

Key Points: 
  • Some of the Major Factors Contributing to the Growth of the Market:
    India Smartphone market report is based on an inclusive study of the entire Indian smartphone market.
  • The report offers the most up-to-date industry data on the actual market situation and future outlook for the India Smartphone market.
  • The report grasps a profound study with size in terms of both value and volume of the Indian smartphone market.
  • This Comprehensive India Smartphone Market Research Report Provides:
    Delivers an In-Depth Analysis of Evolving Market Trends, Drivers and Restraints of the Indian Smartphone Market
    A Comprehensive List of the Key Players Along with the Analysis of their Current Smartphone Portfolios, Business Overview, and Recent Development
    The Major Companies Dominating this Indian Smartphone Market for its Products, Services and Continuous Product Developments are:

India Non-Invasive Prenatal Testing (NIPT) Market and Forecast 2022 - 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 26, 2022
Health, Women, Consumer, Medical Devices, USD, Awareness, Industry, Income, Growth, NIPT, Holocene, CAGR, Medical imaging

The "India Non-Invasive Prenatal Testing (NIPT) Market and Forecast 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "India Non-Invasive Prenatal Testing (NIPT) Market and Forecast 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • India Non-Invasive Prenatal Testing Market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetuses, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing.
  • The report offers the most up-to-date industry data on the actual market situation and future outlook for the India non-invasive prenatal testing market.
  • The India Non-Invasive Prenatal Testing Market Research Report Provides:
    A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development
    The Leading Companies for the Indian Non-Invasive Prenatal Testing Market are Listed Below:

Mysterious ancient tombs reveal 4,500-year-old highway network in north-west Arabia

Retrieved on: 
Monday, January 10, 2022
Neolithic, BCE, Education, Royal Commission for Al-'Ula, Animal, Royal commission, Rain, Conservation, Bronze Age, Tourism, Dadanitic, History, Publication, Travel, Nature, Journey Through Time Scenic Byway, Work, Kayak (band), UWA, Culture, Journal of Field Archaeology, Time, Kingdom, Research, CEO, Vision 2030, Economic development, Antiquity, University, Tayma, Life, Journal, Society, Epigraphy, RCU, Holocene, Oil, Toy, Furniture, Arabian Peninsula, Archaeology, Al-'Ula

AlUla, Saudi Arabia, Jan. 10, 2022 /PRNewswire/ -- Archaeologists from the University of Western Australia (UWA) have determined that the people who lived in ancient north-west Arabia built long-distance 'funerary avenues' – major pathways flanked by thousands of burial monuments that linked oases and pastures – suggesting a high degree of social and economic connection between the region's populations in the 3rd millennium BCE.

Key Points: 
  • The existence of the funerary avenues suggests that complex social horizons existed 4,500 years ago across a huge swathe of the Arabian Peninsula.
  • The finding adds to the steady progress by archaeologists working under the auspices of RCU in understanding the hidden story of the ancient kingdoms and earlier societies of north Arabia.
  • The work done by our archaeological teams in 2021 demonstrates that Saudi Arabia is a home for top-flight science and we look forward to hosting more research teams in 2022."
  • Theyrecorded more than 17,800 'pendant' tombs in their primary study areas of AlUla and Khaybar counties, of which around 11,000 formed part of funerary avenues.

Mysterious ancient tombs reveal 4,500-year-old highway network in north-west Arabia

Retrieved on: 
Monday, January 10, 2022
Neolithic, BCE, Education, Royal Commission for Al-'Ula, Animal, Royal commission, Rain, Conservation, Bronze Age, Tourism, Dadanitic, History, Publication, Travel, Nature, Journey Through Time Scenic Byway, Work, Kayak (band), UWA, Culture, Journal of Field Archaeology, Time, Kingdom, Research, CEO, Vision 2030, Economic development, Antiquity, University, Tayma, Life, Journal, Society, Epigraphy, RCU, Holocene, Oil, Toy, Furniture, Arabian Peninsula, Archaeology, Al-'Ula

The existence of the funerary avenues suggests that complex social horizons existed 4,500 years ago across a huge swathe of the Arabian Peninsula.

Key Points: 
  • The existence of the funerary avenues suggests that complex social horizons existed 4,500 years ago across a huge swathe of the Arabian Peninsula.
  • The finding adds to the steady progress by archaeologists working under the auspices of RCU in understanding the hidden story of the ancient kingdoms and earlier societies of north Arabia.
  • The work done by our archaeological teams in 2021 demonstrates that Saudi Arabia is a home for top-flight science and we look forward to hosting more research teams in 2022."
  • Theyrecorded more than 17,800 'pendant' tombs in their primary study areas of AlUla and Khaybar counties, of which around 11,000 formed part of funerary avenues.

Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes

Retrieved on: 
Thursday, December 30, 2021
Gene, Chronic kidney disease, Annual report, Death, AHA, SGLT2, Disease, Heart failure, Risk, U.S. Securities and Exchange Commission, Gastrointestinal tract, Protein, NDA, Trial of the century, FDA, Cardiovascular disease, File, Kidney, Diabetes, The New England Journal of Medicine, Metabolism, Lexicon Pharmaceuticals, GLOBE, Form 10-K, SGLT1, NEJM, Hospital, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, New Drug Application, Body mass index, Intellectual property, EGFR, Adult, Marketing, Review, Type 2 diabetes, Nasdaq, Security (finance), Holocene, Neuropathic pain, American Heart Association, Sale, Union, Pharmaceutical industry, Lexicon, Patient, EU

SOLOIST was a multi-center, randomized, double-blinded, placebo-controlled Phase 3 study evaluating the cardiovascular efficacy of sotagliflozin versus placebo when added to standard of care in 1,222 patients with type 2 diabetes who had recently been hospitalized for worsening heart failure.

Key Points: 
  • SOLOIST was a multi-center, randomized, double-blinded, placebo-controlled Phase 3 study evaluating the cardiovascular efficacy of sotagliflozin versus placebo when added to standard of care in 1,222 patients with type 2 diabetes who had recently been hospitalized for worsening heart failure.
  • The primary endpoint was the total number of events comprised of deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure in patients treated with sotagliflozin compared with placebo.
  • The primary endpoint was the total number of events comprised of deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure in patients treated with sotagliflozin compared with placebo.
  • Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

Gerber Technology Hosts Hybrid ideation Conference; First Conference as a Lectra Company

Retrieved on: 
Monday, December 13, 2021
OnDemand, Sign, Table, Kornit Digital, Fashion, Collection, Association, Automation, FRWL, CEO, Ideation, LSS, Industry, Solution, AAFA, Technology, Holocene, Innovation Center station, Public relations, Marketing, Twine, Lectra, Carhartt, Euronext

NEW YORK, Dec. 13, 2021 /PRNewswire/ --In October, 1,700 people virtually attended Gerber Technology's annual ideation conference, which marked the beginning of Gerber and Lectra becoming stronger together as one company.

Key Points: 
  • NEW YORK, Dec. 13, 2021 /PRNewswire/ --In October, 1,700 people virtually attended Gerber Technology's annual ideation conference, which marked the beginning of Gerber and Lectra becoming stronger together as one company.
  • ideation 2021 was made possible by 25 technology, media and industry association partners who sponsored the event, inducing WhichPLM, 3DLOOK, and Kornit Digital.
  • Like Lectra, Gerber Technology develops software and automation solutions for fashion, automotive, furniture and other businesses across the globe.
  • By uniting, Lectra and Gerber Technology will become the ultimate Industry 4.0 partner for their customers.